Ra Capital Management, L.P.
RA Capital Management, L.P. is a Boston-based investment firm founded in 2001, specializing in public and private investments in the biotechnology and life sciences sectors. The firm is led by Peter Kolchinsky and Rajeev Shah, and manages significant assets with a focus on innovative healthcare companies. It serves institutional investors and invests across venture capital and public equities strategies, with a dedicated team of over 51-200 employees. RA Capital's expertise centers on supporting transformative science and high-impact healthcare solutions.
Investment Strategy
RA Capital Management pursues a fundamentally driven investment strategy by investing in companies developing groundbreaking solutions in biotechnology, pharmaceuticals, and healthcare. The firm invests across both private and public markets, often supporting companies through multiple stages of their development. Its approach includes deep scientific diligence, a focus on transformative therapeutic areas, and long-term partnership with innovative companies aiming to address unmet medical needs.
Top Holdings
Equity Positions (61)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A ASND | ASCENDIS PHARMA A/S - ADR | 29.90% | $1.77B | 10,281,496 | $82.86 | $172.60 | +$172.1M |
P PCVX | VAXCYTE INC | 6.55% | $389.0M | 11,965,991 | $40.28 | $32.51 | -$71.2M |
R RYTM | RHYTHM PHARMACEUTICALS INC | 5.92% | $351.4M | 5,561,359 | $26.73 | $63.19 | +$29.1M |
J JANX | JANUX THERAPEUTICS INC | 4.35% | $258.5M | 11,189,693 | $27.51 | $23.10 | -$43.6M |
R RNA | AVIDITY BIOSCIENCES INC | 3.48% | $206.4M | 7,266,031 | $31.37 | $28.40 | +$20.4M |